Asthma inhalers are, on balance, among the most important medications in modern medicine and have dramatically reduced asthma deaths over the past three decades. They are not “bad for you” in the way the question implies, but they are not side-effect-free either. The risks depend heavily on which type of inhaler you use, how much of it you use, and whether you use it correctly. Understanding those distinctions matters more than any blanket verdict.
How Inhaled Steroids Changed Asthma Mortality
Before inhaled corticosteroids became widely prescribed in the 1990s, asthma killed far more people than it does today. The widespread adoption of these anti-inflammatory inhalers is credited as a major reason asthma death rates fell so sharply.1PubMed Central. Asthma progression and mortality: the role of inhaled corticosteroids One large study calculated that the risk of dying from asthma dropped by roughly 21 percent with each additional canister of inhaled corticosteroid used in the prior year.2PubMed. Low-dose inhaled corticosteroids and the prevention of death from asthma That is a striking benefit from a medication people sometimes avoid because they worry it might harm them.
The concern people express is understandable. The word “steroid” carries heavy baggage, and nobody loves the idea of inhaling a drug every day, possibly for life. But the key context is what you are comparing the inhaler to. You are not comparing it to perfect health. You are comparing it to uncontrolled asthma, which causes airway remodeling, emergency hospitalizations, and death. Against that backdrop, the side effects of properly used inhalers are real but generally manageable, and the trade-off tilts heavily in favor of treatment.
Rescue Inhalers and the Problem of Overuse
The blue rescue inhaler most people picture when they think “asthma inhaler” contains a short-acting beta-agonist, usually albuterol or salbutamol. It works fast by relaxing the muscles around your airways. The issue is not occasional use during a flare-up. The issue is relying on it too heavily, which many people do, sometimes because they skip their daily controller inhaler and use the rescue puff instead.
A large nationwide study following the global SABINA research program found that people who went through three to five rescue canisters per year had about a 26 percent higher risk of asthma flare-ups compared to those using two or fewer. At six to ten canisters per year, the risk climbed further, and at eleven or more canisters, flare-up risk was roughly 77 percent higher. Mortality followed the same pattern: those using eleven or more canisters a year had more than double the death risk compared to low users.3European Respiratory Journal. Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme A separate systematic review pooling data from multiple studies confirmed the pattern, finding that people using three or more rescue canisters per year had roughly double the risk of both death and severe flare-ups compared to lower users.4PubMed Central. Adverse Outcomes Associated With Short-Acting Beta-Agonist Overuse in Asthma: A Systematic Review and Meta-Analysis
There is an important nuance here. High rescue inhaler use is partly a marker of poorly controlled asthma, not purely a cause of bad outcomes. Someone reaching for their rescue puff ten times a week probably has underlying inflammation that is not being treated. Still, there are also pharmacological reasons to worry about overuse. Beta-agonists can cause a racing heart, tremor, and drops in blood potassium. A review of cardiovascular effects over the past decade flagged tachycardia, heart rhythm changes, and low blood pressure, with children on continuous therapy being more susceptible to electrolyte problems.5PubMed Central. A 10-year interval of cardiovascular effects of albuterol in asthma management: Graphical review These effects happen because beta-agonist drugs, while designed for lung receptors, can spill over and activate heart receptors too, causing a faster heart rate and symptoms like headache or dizziness.6PubMed Central. Utility of inhaled β2-agonists in reducing serum potassium levels in adult patients with hyperkalemia: A scoping review
Over time, heavy use of beta-agonists can also make the receptors in your airways less responsive, a phenomenon called tachyphylaxis. Lab studies on human airway muscle showed that this desensitization is dose-dependent and crosses over to other similar drugs, though it does reverse when you stop the medication.7PubMed Central. Tachyphylaxis to beta-adrenoceptor agonists in human bronchial smooth muscle: studies in vitro In practical terms, the more you lean on your rescue inhaler, the less effective each puff becomes, which can set up a dangerous cycle of escalating use.
The LABA Monotherapy Scare and Why It Changed Everything
Long-acting beta-agonists like salmeterol and formoterol provide hours of airway relaxation and are commonly found in combination inhalers. But they generated serious safety alarms when used alone. The SMART trial in the United States was stopped after an interim analysis of about 26,000 patients showed a roughly four-fold increase in asthma deaths among people taking salmeterol compared to placebo.8European Respiratory Journal. Safety of long-acting β-agonists: urgent need to clear the air remains A broader systematic review confirmed that using long-acting beta-agonists as monotherapy was associated with nearly a four-fold increase in asthma-related deaths.9Pulmonary Pharmacology & Therapeutics. Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review
The mechanism appears to be that long-acting bronchodilators mask worsening inflammation. Your airways feel open, so you feel fine, but the underlying disease progresses unchecked until a severe or fatal attack strikes. This is why these drugs are now almost never prescribed alone. They come packaged in combination inhalers with an anti-inflammatory corticosteroid, and clinical guidelines explicitly warn against using them solo. If you are on a combination inhaler that contains both a steroid and a long-acting beta-agonist, the safety picture is much better than what the SMART trial showed.
Mouth, Throat, and Dental Effects
The most common side effects people notice from steroid inhalers are local ones. Inhaled corticosteroids suppress the immune environment in your mouth and throat, which can allow a yeast called Candida albicans to overgrow, producing white patches and soreness known as oral thrush.10PubMed Central. Non-Pharmacological Interventions to Prevent Oropharyngeal Candidiasis in Patients Using Inhaled Corticosteroids: A Narrative Review Hoarseness is another frequent complaint, caused by steroid deposition on the vocal cords.
Dental health is a less recognized casualty. Inhaler use, particularly from metered-dose devices, has been linked to higher rates of dental decay, fissured tongue, dry mouth, and dental erosion compared to people not using inhalers.11Journal of Iranian Medical Council. Oral Manifestations in Asthmatic Patients Using Metered Dose Inhaler and Dry Powder Inhaler A study of children and adolescents also found a significant association between inhaler use and erosive dental lesions.12PubMed. Dental erosion. Etiologic factors in a sample of Valencian children and adolescents. Cross-sectional study Part of the mechanism is dry mouth: beta-agonists and corticosteroids both reduce saliva flow, and saliva is your mouth’s main defense against acid and bacterial damage.
These local effects are largely preventable with good technique. Using a spacer device with a metered-dose inhaler reduces how much drug deposits in your mouth and throat. Rinsing your mouth with water after each puff, and spitting rather than swallowing, cuts down systemic absorption and washes away residual drug.13PubMed. Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler Many people skip both steps, which is a significant contributor to the side effects they experience.
Growth in Children
This is probably the concern that generates the most anxiety among parents. And the evidence is not dismissible: inhaled corticosteroids do slow growth velocity, particularly in the first year of treatment, by about one centimeter per year.14European Respiratory Journal. Inhaled corticosteroids reduce growth. Or do they? That slowdown tends to plateau after the first year, and most data at standard doses suggest it does not translate into a clinically meaningful reduction in adult height for most children.
However, one well-designed long-term study from the Childhood Asthma Management Program followed participants into adulthood and found that children who used budesonide ended up about 1.2 centimeters shorter as adults compared to those on placebo. The reduction tracked with the dose used in the first two years of treatment.15PubMed Central. Effect of inhaled glucocorticoids in childhood on adult height That is a small but real and apparently permanent effect. A review of the broader literature concluded that the data on final adult height remain somewhat conflicting, though the pattern of a small, dose-dependent growth effect across the first year of use is consistent.16PubMed Central. The effects of inhaled corticosteroids on growth in children
For parents weighing this, about a centimeter of adult height is real, but poorly controlled asthma in childhood also impairs growth and carries risks of emergency room visits and long-term airway damage. The calculus almost always favors treating the asthma, but it is one reason pediatric guidelines emphasize using the lowest effective dose of inhaled corticosteroid rather than defaulting to higher doses.
Bones, Adrenal Glands, and Eyes
Systemic corticosteroids like prednisone are notorious for weakening bones. Inhaled corticosteroids are designed to stay mostly in the lungs, but some drug inevitably gets absorbed into the bloodstream, especially at higher doses. The evidence suggests low and medium doses have little to no effect on bone density, and are far safer than the oral steroids they often replace. At doses above about 2,000 micrograms per day of an older inhaled steroid, some bone loss becomes a concern, though it remains less severe than what oral corticosteroids cause.17Journal of Allergy and Clinical Immunology. Effects of inhaled corticosteroids on bone density and metabolism
Adrenal suppression is another systemic risk. Your adrenal glands normally produce cortisol, and inhaling a corticosteroid tells the body it has enough, so the glands dial back. A study of children on inhaled steroids found suppressed cortisol levels in about a quarter of them, with longer duration and higher doses both increasing the risk.18PubMed Central. Effect of long term inhaled corticosteroid therapy on adrenal suppression, growth and bone health in children with asthma Adrenal suppression is usually subclinical, meaning the tests are abnormal but the child is not showing symptoms. But in rare cases, abruptly stopping a high-dose inhaled steroid can trigger an adrenal crisis, so doctors recommend tapering rather than sudden discontinuation when stepping down from high doses.
Eye effects are a longer-term concern. A systematic review found that daily high-dose inhaled corticosteroids at 1,000 micrograms or above are associated with a meaningful increase in cataract risk.19PubMed Central. Inhaled Corticosteroid Exposure and Risk of Cataract in Patients with Asthma and COPD: A Systematic Review and Meta-Analysis A large population study found that long-term users of inhaled corticosteroids had about 50 percent higher prevalence of nuclear cataracts and roughly double the prevalence of posterior subcapsular cataracts compared to non-users. The risk was strongly tied to cumulative lifetime dose, with the highest exposure group having a 27 percent prevalence of posterior subcapsular cataracts.20PubMed. Use of inhaled corticosteroids and the risk of cataracts At standard low-to-moderate doses, this is not a first-year concern. It becomes relevant for people who stay on high-dose inhaled steroids for many years.
There is also some evidence linking high-dose inhaled corticosteroids to increased pneumonia risk. A case-control study found that people on the highest-strength inhaled steroid prescriptions had about double the risk of pneumonia or lower respiratory tract infection compared to people with asthma who were not using inhaled steroids.21PubMed. Inhaled corticosteroids and the risk of pneumonia in people with asthma: a case-control study This risk is dose-dependent and more often discussed in the COPD literature, but it applies to asthma patients on higher doses as well.
Steroid Phobia and Its Costs
Between 19 and 67 percent of asthma patients or their parents report significant fear of inhaled corticosteroids, depending on the population studied. The specific worries include growth suppression, weight gain, bone weakening, addiction, and psychiatric effects. Of those, growth suppression is the one with real supporting data, as described above. Weight gain, addiction, and psychiatric effects from standard inhaled doses are not supported by evidence and are considered misconceptions.22PubMed. Inhaled corticosteroid-phobia and childhood asthma: Current understanding and management implications
Steroid phobia consistently leads to worse asthma control. People who fear their controller inhaler skip doses, cut themselves down to less than what was prescribed, or abandon it entirely and rely on rescue puffs. That creates the very pattern of rescue inhaler overuse associated with worse outcomes. In a frustrating irony, the fear of side effects often leads to the behavior that causes the most harm.
How Modern Guidelines Have Shifted
The global approach to asthma treatment has changed substantially in recent years, driven largely by the rescue inhaler overuse data. The 2024 Global Initiative for Asthma (GINA) guidelines now recommend that all adults and adolescents with asthma receive inhaled corticosteroid-containing medication and should not be treated with a short-acting rescue inhaler alone.23PubMed Central. Update on Asthma Management Guidelines The preferred approach is using a combination of a low-dose corticosteroid and formoterol as your rescue inhaler, so that every time you reach for relief, you are also getting a small dose of anti-inflammatory medication.24PubMed Central. Anti-Inflammatory Reliever Therapy in Asthma: A Review Alternatively, guidelines support using a rescue beta-agonist paired with a separate corticosteroid inhaler.25PubMed. Budesonide/Formoterol or Budesonide/Albuterol as Anti-Inflammatory Reliever Therapy for Asthma
This “anti-inflammatory reliever” concept is a direct response to the finding that SABA-only treatment leaves asthma inflammation untreated. If your doctor recently changed your prescription from a standalone blue rescue inhaler to a combination puff, this is why. The evidence from randomized trials shows a substantial reduction in severe flare-ups when every rescue puff includes a steroid.
Pregnancy and Inhaler Safety
Pregnant women with asthma sometimes worry about whether to continue their inhalers. Global guidelines are clear on this: continue using asthma medications throughout pregnancy. The risks of uncontrolled asthma to both mother and baby, including low birth weight, preterm delivery, and preeclampsia, outweigh the risks of the medications. Inhaled corticosteroids, short-acting beta-agonists, long-acting beta-agonists, and several other categories are considered justified during pregnancy.26PubMed Central. Breathing for Two: Asthma Management, Treatment, and Safety of Pharmacological Therapy during Pregnancy Stopping your inhaler to “protect the baby” can make things worse for both of you.
The Carbon Footprint of Your Inhaler
One dimension of “bad for you” that has gained attention recently is environmental rather than personal. Metered-dose inhalers use pressurized gas propellants to push medication out of the canister, and those propellants are potent greenhouse gases. The propellants in MDIs account for roughly 13 percent of the UK National Health Service’s carbon footprint from direct care delivery.27PubMed. The environmental impact of inhalers for asthma: A green challenge and a golden opportunity
Dry-powder inhalers, which rely on your own inhalation effort rather than a propellant, have a vastly smaller carbon footprint. One analysis estimated that a year of using all-MDI inhalers for a single patient produced roughly 439 kilograms of carbon dioxide equivalent, while the same medications in dry-powder form came to about 17 kilograms. In England, about 70 percent of inhalers sold were MDIs, compared to just 13 percent in Sweden. If England matched Sweden’s device mix, the annual reduction would be about 550,000 tonnes of COâ‚‚ equivalent.28PubMed Central. Carbon footprint impact of the choice of inhalers for asthma and COPD
This does not mean you should switch devices without medical advice. Some patients, especially young children and elderly adults, cannot generate enough airflow to use a dry-powder inhaler effectively. And a switch that worsens your asthma control defeats the purpose. But if your doctor offers you a choice between a propellant inhaler and a dry-powder device, and both work equally well for you, the dry-powder version is the greener option by a wide margin.
Rare Allergic Reactions to Inhaler Ingredients
In uncommon cases, people react not to the active drug in their inhaler but to the drug molecule itself or the inactive ingredients. Patch testing has identified patients who are genuinely allergic to specific corticosteroid molecules like budesonide, experiencing severe rashes or worsening respiratory symptoms from the very medication supposed to help them. One documented case involved a patient who developed widespread eczema from beclomethasone and oropharyngeal irritation with shortness of breath from fluticasone, while another had a severe skin rash after just four budesonide inhalations.29PubMed. Corticosteroid allergy in asthma These reactions are rare enough that most clinicians never encounter them, but they are worth knowing about if your inhaler consistently seems to make things worse rather than better. The fix is usually switching to a different corticosteroid molecule, since cross-reactivity between steroid classes is not universal.
Diabetes Risk at High Doses
At standard low and moderate doses, inhaled corticosteroids have little systemic metabolic impact. But at high doses, where more drug enters the bloodstream, the metabolic effects begin to resemble those of oral steroids. A large cohort study of patients on inhaled corticosteroids found a statistically significant 34 percent increase in the incidence of type 2 diabetes among those using higher inhaled steroid doses, with the risk tied specifically to dose level.30The Open Respiratory Medicine Journal. Systemic Effects of Inhaled Corticosteroids: An Overview This is primarily a concern for people on long-term high-dose regimens, not for someone taking a couple of puffs of low-dose budesonide each morning.